Drug Database
ME

mesalazine (Rowasa / Pentasa enema / Pentasa foam enema)

✓ Approved

Nisshin Pharma · PTGS1 · 小分子

什么是 mesalazine?

mesalazine 是一种小分子,由Nisshin Pharma研发。该药已获批,用于治疗相关适应症,给药途径:Rectal。

药物档案

商品名Rowasa, Pentasa enema, Pentasa foam enema
公司Nisshin Pharma
药物类别小分子
分子靶点PTGS1, PTGS2
给药途径Rectal
状态Approved

作用机制

分子靶点

mesalazine 作用于 2 个分子靶点:

PTGS1prostaglandin-endoperoxide synthase 1 (COX3, PCOX1)
PTGS2prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

mesalazine 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Gastrointestinal disordersColitis ulcerative✓ Approved
Gastrointestinal disordersCrohn's disease✓ Approved

相关研究文献

PubMedJournal of Ayurveda and integrative medicine2026-11-18

Ayurvedic management of mixed-type obsessive-compulsive disorder along with comorbid depression (Atatvabhinivesha): A case report.

Malviya Vishalraj V, Dalshaniya Pina P, Gupta Shivenarain N SN, Patel Manish V MV et al.

Obsessive-compulsive disorder (OCD) is a chronic and debilitating neuropsychiatric condition characterised by persistent intrusive thoughts and repetitive behaviours performed to alleviate anxiety or distress. Ayurveda describes a similar entity, Atatvabhinivesha, a Manovikara characterised by delusional adherence to false beliefs due to Rajo-tamo vitiation. A 34-year-old male, pre-diagnosed with mixed type OCD with comorbid depression, presented to Ayurvedic hospital with obsessive cleaning rituals, intrusive thoughts, disturbed sleep with hypnic jerks, and sustained anxiety for two years. Despite two months of conventional treatment, symptom control remained inadequate. The patient was managed through Panchakarma [Virechana Karma (∼purgation therapy), Basti Karma (∼enema therapy), Nasya Karma (∼nasal drops therapy)] followed by oral Medhya Rasayana for 45 days of IPD. Oral Medhya Rasayana was prescribed with Pathya-apathya for the next 5 months in OPD. Daivavyapashraya chikitsa [Gayatri Mantra chanting, Havan, meditation, Moti Dharana, etc.] was also performed throughout the treatment. Marked reduction in HAM-D (26 to 5), Y-BOCS (28 to 6) scores, and almost complete relief in symptoms were observed. The quality of life of the patient was also improved. The conventional medicine dosage was reduced in a tapering dose up to 3 months and was completely stopped by the patient after 3 months of Ayurvedic treatment without any symptomatic aggravation. Even after 1 year from the date of admission, no relapse was observed, despite discontinuation of all oral medications for the past six months. This case highlights the efficacy of Ayurvedic treatment in OCD comorbid with depression management without any clinically apparent or patient-reported adverse effects during the treatment period.

PMID 43050936
阅读全文 →
PubMedZhen ci yan jiu = Acupuncture research2026-11-18

[Temperature-dependent effects of thermal stimulation at "Zusanli" (ST36) on visceral hyperalgesia and SRD neuronal electrical activity in rats with acute colonic mucosal injury].

Li Yani Y, Zhang Zhiyun Z, Sun Xiaoyue X, Wang Xiaoyu X et al.

To observe the effect and dose-response relationship of thermal stimulation at "Zusanli" (ST36) with different temperatures on alleviating visceral hyperalgesia in rats with acute colonic mucosal injury, so as to explore its underlying mechanism focusing on the electrical activity of the subnucleus reticularis dorsalis (SRD) in the medulla. (1) Eighteen SD rats were randomly divided into normal and model groups, with 9 rats in each group. The acute colonic mucosal injury model was established by mustard oil enema. The structural and pathological changes of colonic tissue were observed by colonoscopy and HE staining. The expressions of calcitonin gene-related peptide (CGRP) and transient receptor potential vanilloid 1 (TRPV1) in rat colonic tissue were detected by immunofluorescence staining. (2) Thirty SD rats were randomly divided into normal group, model group, 44 ℃, 48 ℃, and 52 ℃ thermal stimulation groups (n=6 in each group). After modeling, thermal stimulation with the corresponding temperature was applied to "Zusanli" (ST36) in each stimulation group. Visceral pain was induced by colorectal distension. The area under the curve (AUC) of rectus abdominis electromyogram (EMG) was evaluated by EMG recording, and the inhibition rate of noxious EMG by thermal stimulation at different temperatures was calculated. (3) Pseudorabies virus (PRV) retrograde tracing was employed in 3 normal rats to label SRD neurons receiving dual projections from both ST36 and the colon. (4) Twenty-four model rats were randomly divided into 44 ℃, 48 ℃, and 52 ℃ thermal stimulation groups, with 8 rats in each group. Multi-channel in vivo electrophysiological technique was used to record the electrical activity of SRD neurons. The changes in SRD neuronal firing within 1 h of acute mustard oil perfusion and the inhibitory effect of thermal stimulation at different temperatures on their firing were observed. After modeling and compared with the normal group, the rats' colonic mucosa showed congestion, edema, structural destruction, and obvious inflammatory cell infiltration, with significantly increased distribution of CGRP and TRPV1 positive nerve fibers (P<0.05) and a significantly increased AUC of rectus abdominis EMG (P<0.001). Compared with the model group, After 48 ℃ and 52 ℃ thermal stimulation, the evoked rectus abdominis EMG was significantly reduced (P<0.001);while there was no statistically significant difference in AUC after 44℃ thermal stimulation. The inhibition rates at 48 ℃ and 52 ℃ were significantly higher than that at 44℃ (P<0.05), with no significant difference between 48 ℃ and 52 ℃. Morphologically, PRV retrograde tracing revealed neurons in the medullary SRD region that were single-labeled from the colon or ST36, as well as double-labeled neurons. Electrophysiologically, the firing frequency of SRD neurons increased rapidly at 5 min after mustard oil instillation, and the increase persisted for 30 min (P<0.05). During this high-firing period, thermal stimulation at 48 ℃ and 52 ℃ significantly suppressed the firing frequency (P<0.01, P<0.05), whereas 44 ℃ stimulation had no such effect. Noxious thermal stimulation at 48 ℃ and 52 ℃ can effectively alleviate visceral hyperalgesia in rats with acute colonic mucosal injury, which may be related to inhibiting nociceptive discharge of medullary SRD neurons. Considering both central inhibitory effect and local skin safety, 48 ℃ appears to be the optimal intervention temperature.

PMID 43051687
阅读全文 →
PubMedZhonghua wei zhong bing ji jiu yi xue2026-11-17

[Design and application of a flushable anal pouch with enema function].

Chen Taiming T, Zhang Liheng L, Li Xuezhu X, Wang Wenchun W et al.

In the field of emergency and critical care medicine, the number of patients requiring enema due to severe acute pancreatitis, enterostomy, defecation dysfunction and preoperative intestinal preparation has increased year by year. In recent years, traditional Chinese medicine enemas has also become an increasingly important therapeutic measure. Conventional anal bags are only capable of fecal collection, with prominent defects including inaccurate volume measurement, complicated enema procedures, high risk of fecal leakage and heavy a burden for nosocomial infection control. Repeated enema administration and subsequent perianal care not only increase nursing workload but also tend to trigger various complications. To address the above clinical dilemmas, the medical staff from the department of critical care medicine of Zhongda Hospital Affiliated to Southeast University developed a flushable anal pouch with enema function, which has been granted a National Utility Model Patent of China (ZL 2021 2 1111805.5). Modified and optimized based on the structure of traditional anal bags, this device integrates multiple functions such as enema therapy, closed fecal collection, precise fecal measurement and bag flushing. It enables one-stop completion of enema treatment and defecation nursing, which markedly improves the efficiency of clinical nursing work. Adopting a fully closed structure, the device can effectively protect the skin around the anus and stoma, reduce complications including mucosal injury, oozing and infection, and enable accurate monitoring of fecal volume to better meet the demands of disease assessment, diagnosis and treatment for critically ill patients. Its structure is designed in accordance with human physiological characteristics; it fits the physiological curve of human body for stable fixation and favorable adaptability. The integrated multi-function design cuts down the consumption of medical supplies and reduces medical costs, and the device is suitable for bed units in general wards and intensive care units (ICU). Closely, meeting the actual clinical nursing demands, the device is easy to operate and highly practical, which presents great value for clinical popularization and application.

PMID 43045528
阅读全文 →
PubMedPakistan journal of medical sciences2026-11-17

The Effectiveness of Oral Lactulose Versus Lactulose Enema on the Time to Recovery from Overt Hepatic Encephalopathy.

Badshah Aliena A, Irtaza Ahmed A, Khan Arooba A, Khan Qaisar Ali QA

To compare efficacy of lactulose retention enema with oral lactulose therapy in terms of time to one grade improvement in hepatic encephalopathy (HE) and time to complete recovery from overt hepatic encephalopathy. This, open-label single blinded randomized controlled trial was conducted at Khyber Teaching Hospital, Peshawar from July to December 2024. The study protocol was registered with Clinicaltrials.gov with the ID: NCT05788627. The trial enrolled 100 patients with Grade-III/IV hepatic encephalopathy precipitated by constipation. Patients were randomly assigned to oral or enema lactulose therapy - Clinical Arm 1 -CA1 and Clinical Arm 2 -CA2 respectively. Patients in CA1 received oral lactulose and placebo (plain water) enema, while patients in CA2 received oral lactulose alongside lactulose enema. The primary end points were time to one grade improvement and complete recovery. Data were analyzed using IBM SPSS 26.0. Qualitative variables were compared using Chi-square test and Intergroup comparison was done using independent samples T-test where needed. A p-value of < 0.05 was considered statistically significant. "Mean time for one grade improvement in hepatic encephalopathy" was 38.05 hours in CA1 while 30.13 hours in CA2 (p value 0.008). "Mean time to complete recovery from hepatic encephalopathy" in hours was 70.16 in CA1 and 54.86 in CA2 (p value 0.000). A statistically significant difference was noted in "Mean number of Doses required to bring about one grade improvement" (3.2 vs 4.9 in CA1 and CA2 respectively). Lactulose enema in combination with oral lactulose shows faster improvement in the HE grades and quicker overall recovery in clinical status in overt HE patients as compared to oral lactulose alone.

PMID 43041894
阅读全文 →
PubMedTurkish archives of pediatrics2026-11-17

Effectiveness and Safety of Surgical and Advanced Interventional Treatments for Pediatric Refractory Constipation: A Systematic Review with Domain-Specific Meta-analyses of Proportions.

Aldaz Vallejo Freddy Alexander FA, Oliveros-Rivero Jorge J, Patiño González Celeste Carolina CC

To synthesize clinical outcomes and safety of surgical and advanced interventional treatments for pediatric refractory constipation using a phenotype-directed, domain-specific approach. This systematic review with domain-specific meta-analyses of proportions followed PRISMA 2020 and was prospectively registered in PROSPERO (CRD420261378728). PubMed/MEDLINE, Embase, Scopus, Web of Science, CENTRAL, the Cochrane Library, LILACS, trial registries, Google Scholar, and reference lists were searched through April 29, 2026. Eligible interventions included antegrade continence enema (ACE) procedures, botulinum toxin injection, transanal irrigation (TAI), diversion, and selected resective or motility-guided procedures. Random-effects single-arm proportions were pooled only within clinically coherent domains; safety outcomes were synthesized structurally when definitions and denominators were not sufficiently comparable for pooling. Thirty-two primary interventional studies met final eligibility criteria, of which 22 contributed to quantitative synthesis. Descriptive pooled study-defined clinical success or response was 85% (95% CI: 81%-88%) for ACE procedures, 81% (95% CI: 72%-89%) for botulinum toxin injection, 81% (95% CI: 64%-94%) for TAI, and 91% (95% CI: 76%-100%) for resective or advanced surgery. The surgical estimate was exploratory because procedures and indications were heterogeneous. These proportions are not comparative treatment-effect estimates. Certainty of evidence was low or very low, and safety reporting was inconsistent across studies. Advanced interventions may be associated with favorable outcomes in carefully selected children with refractory constipation, but indications and risks are phenotype specific. The evidence does not support direct effectiveness comparisons between therapeutic domains.

PMID 43041032
阅读全文 →
PubMedZhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica2026-11-17

[Pharmacokinetics of Baizhu San in normal and diarrhea-predominant irritable bowel syndrome model rats].

Chen Qin Q, Zhu Wei-Feng WF, Hu Pei P, Yang Lin L et al.

An ultra-performance liquid chromatography-triple quadrupole tandem mass spectrometry(UPLC-QqQ-MS/MS) method was established for the simultaneous quantification of seven absorbed components(pogostone, puerarin, daidzin, 3'-methoxypuerarin, glycyrrhizic acid, glycyrrhetinic acid, and ginsenoside Rb_1) in Baizhu San(BZS). This method was subsequently employed to investigate the pharmacokinetics of these components in normal rats and in a rat model of diarrhea-predominant irritable bowel syndrome(IBS-D), on the basis of which the impact of disease status on the pharmacokinetics of the active components in this classic formula was evaluated. The IBS-D rat model was established via acetic acid enema combined with gavage of senna leaf extract and restraint stress. Following gavage of BZS, blood samples were collected at various time points from the orbital sinus of rats in each group. Plasma concentrations of the components were determined through the established UPLC-QqQ-MS/MS method, and pharmacokinetic parameters were calculated in Phoenix WinNonlin 8.1 software. The results showed that compared with the control group, the model group showed decreased AUC of puerarin, daidzin, and 3'-methoxypuerarin(P<0.05). For pogostone, T_(max), AUC, and MRT were significantly decreased in the model group. The AUC, t_(1/2), C_(max), and MRT of ginsenoside Rb_1 and glycyrrhizic acid were all increased, while the AUC of glycyrrhetinic acid showed a decreasing trend in the model group. Collectively, these results indicate that the pharmacokinetic profile of BZS differs between normal and model animals, which may be attributed to intestinal microbiota dysbiosis, abnormal intestinal motility, and intestinal barrier damage under IBS-D conditions, thereby influencing the absorption and elimination of the active components. This study provides a scientific basis for the rational clinical application of BZS.

PMID 43045135
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多mesalazine